Sample size calculations for evaluating treatment policies in multi-stage designs

Clinical Trials

Volumn 7, Issue 6, 2010, Pages 643-652

  Dawson, Ree ^a   Lavori, Philip W ^b  

^a FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BAYES THEOREM; CLUSTER ANALYSIS; COVARIANCE; EVALUATION; MATHEMATICAL COMPUTING; METHODOLOGY; POLICY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SAMPLE SIZE; SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZED DESIGN; SIMULATION;

ALGORITHMS; BAYES THEOREM; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; SAMPLE SIZE; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 78650346527     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774510376418     Document Type: Article

References (16)

1. Dawson R., Green AI, Drake RE, et al. Developing and testing adaptive treatment strategies using substance-induced psychosis as an example. Psychopharmacol Bull 2008 ; 41: 51-67.
2. Lavori PW, Dawson R. Adaptive treatment strategies in chronic disease. Annu Rev Med 2008 ; 59: 443-53.
3. Murphy S. An experimental design for the development of adaptive treatment strategies. Stat Med 2005 ; 24: 1455-81.
4. Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clin Trials 2004 ; 1: 9-20.
5. Oetting AI, Levy JA, Weiss RD, Murphy SA Statistical methodology for a SMART design in the development of adaptive treatment strategies. In Shrout PE. (ed.). Causality and Psychopathology: Finding the Determinants of Disorders and their Cures. Oxford University Press, USA, 2009.
6. Dawson R., Lavori PW Sequential causal inference: application to randomized trials of adaptive treatment strategies. Stat Med 2008 ; 27: 1626-45.
7. Thall PF, Millikan RE, Sung HG Evaluating multiple treatment courses in clinical trials. Stat Med 2000 ; 19: 1011-28.
8. Lunceford JK, Davidian M., Tsiatis AA Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 2002 ; 58: 48-57.
9. Bembom O., van der Laan MJ Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules. Stat Med 2008 ; 27: 3689-716.
10. Lavori PW, Dawson R. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies. Clin Trials 2007 ; 4: 297-308.
11. Lokhnygina Y., Helterbrand JD Cox regression methods for two-stage randomization designs. Biometrics 2007 ; 63: 422-28.
12. Wahed AS, Tsiatis AA Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics 2004 ; 60: 124-33.
13. Wolbers M., Helterbrand JD Two-stage randomization designs in drug development. Stat Med 2008 ; 27: 4161-74.
14. Feng W., Wahed AS Sample size for two-stage studies with maintenance therapy. Stat Med 2009 ; 28: 2028-41.
15. Murphy SM, van der Laan MJ, Robins JM Marginal mean models for dynamic regimes. J Am Stat Assoc 2001 ; 96: 1410-23.
16. Dawson R., Lavori PW Efficient design and inference for multi-stage randomized trials of individualized treatment policies". COBRA Preprint Series. Article 69, 2010. Available at: http://biostats.bepress.com/cobra/ps/ art69.